BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36438793)

  • 1. Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models.
    Cai XJ; Li RD; Li JH; Tao YF; Zhang QB; Shen CH; Zhang XF; Wang ZX; Jiao Z
    Front Pharmacol; 2022; 13():1031969. PubMed ID: 36438793
    [No Abstract]   [Full Text] [Related]  

  • 2. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.
    Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J
    Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
    Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
    J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome.
    Li L; Zhu M; Li DY; Guo HL; Hu YH; Xu ZY; Jing X; Chen F; Zhao F; Li YM; Xu J; Jiao Z
    Int Immunopharmacol; 2021 Sep; 98():107827. PubMed ID: 34284341
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ji E; Kim MG; Oh JM
    Ther Clin Risk Manag; 2018; 14():2119-2126. PubMed ID: 30498355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.
    Lee JY; Hahn HJ; Son IJ; Suh KS; Yi NJ; Oh JM; Shin WG
    Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
    Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients.
    Cai X; Song H; Jiao Z; Yang H; Zhu M; Wang C; Wei D; Shi L; Wu B; Chen J
    Eur J Pharm Sci; 2020 Sep; 152():105448. PubMed ID: 32621968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.
    Zhu J; Campagne O; Torrice CD; Flynn G; Miller JA; Patel T; Suzuki O; Ptachcinski JR; Armistead PM; Wiltshire T; Mager DE; Weiner DL; Crona DJ
    Clin Transl Sci; 2021 May; 14(3):908-918. PubMed ID: 33502111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients.
    Cai X; Li R; Sheng C; Tao Y; Zhang Q; Zhang X; Li J; Shen C; Qiu X; Wang Z; Jiao Z
    Eur J Pharm Sci; 2020 Mar; 145():105237. PubMed ID: 32001346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
    Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
    Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus.
    Wang CB; Zhang YJ; Zhao MM; Zhao L
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110866. PubMed ID: 37678026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating nonlinear kinetics to improve predictive performance of population pharmacokinetic models for ciclosporin in adult renal transplant recipients: A comparison of modelling strategies.
    Mao J; Jiao Z; Qiu X; Zhang M; Zhong M
    Eur J Pharm Sci; 2020 Oct; 153():105471. PubMed ID: 32682934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose.
    Bergmann TK; Hennig S; Barraclough KA; Isbel NM; Staatz CE
    Ther Drug Monit; 2014 Feb; 36(1):62-70. PubMed ID: 24089074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
    Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
    Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CYP3A5, ABCB1 and POR*28 polymorphisms on pharmacokinetics of tacrolimus in the early period after renal transplantation.
    Ling J; Dong LL; Yang XP; Qian Q; Jiang Y; Zou SL; Hu N
    Xenobiotica; 2020 Dec; 50(12):1501-1509. PubMed ID: 32453653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
    Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
    Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of drug combination on tacrolimus target dose in renal transplant patients with different
    Zhang SF; Tang BH; Wei AH; Du Y; Guan ZW; Li Y
    Xenobiotica; 2022 Mar; 52(3):312-321. PubMed ID: 35395919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.